The Indian market is expected to trade higher on January 15, supported by positive global cues. Nifty futures gained 0.51% on ...

Shares of several companies including BSE, SBI Life Insurance, UltraTech Cement, and Ambuja Cements, among others, will be in ...

The Nifty50 had a gap-up opening at 23,216.50 on Tuesday and ended the day at 23,176.05, up 0.39% from Monday's close.

Biocon’s shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to ’Buy’ with a target price of ₹430, ...

Indian stock market rebounded on January 14, marking a recovery after four consecutive sessions of selling pressure that had ...

HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per ...

With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...

AM(IST)on Tuesday in an upbeat market. Biocon Ltd.(up 2.62 per cent), Natco Pharma Ltd.(up 2.45 per cent), Granules India Ltd ...

Stocks in India are expected to stabilize after a significant drop, with Nifty futures showing a slight increase. Despite ...

The market may attempt a rebound amid likely consolidation; however, the overall sentiment remains bearish. Below are some ...